Bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment
RxNorm 2539801
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2539801 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Bacitracin zinc 0.00048 mg/MG / neomycin sulfate 0.01 mg/MG / polymyxin B sulfate 0.006 mg/MG Topical Ointment
(Atom ID: 12627523)
PSN
Prescribable Name (PSN):
Bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment
(Atom ID: 12627524)
SY
Synonym (SY):
Bacitracin zinc 0.048 % / neomycin sulfate 1 % / polymyxin B sulfate 0.6 % Topical Ointment
(Atom ID: 12627525)
Patient Education
Neomycin, Polymyxin, and Bacitracin Topical
Neomycin, polymyxin, and bacitracin combination is used to prevent minor skin injuries such as cuts, scrapes, and burns from becoming infected. Neomycin, polymyxin, and bacitracin are in a class of medications called antibiotics. Neomycin, polymyxin, and bacitracin combination works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.